Skip to content
10-K

Annual Report

BIOPLUS LIFE CORP

0001493152-20-009844

← back to feed
Filed
May 26, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2019 · May 26, 2020 362.91M sh
Capex FY 2019 · Dec 31, 2018 $205.28K
Operating Cash Flow FY 2019 · Dec 31, 2018 −$146.45K
Cash And Equivalents FY 2019 · Dec 31, 2018 $398.13K
Current Liabilities FY 2019 · Dec 31, 2018 $976.35K
Total Liabilities FY 2019 · Dec 31, 2018 $1.67M
Current Assets FY 2019 · Dec 31, 2018 $1.28M
Total Assets FY 2019 · Dec 31, 2018 $3.47M
Sga Expense FY 2019 · Dec 31, 2018 $1.15M
Net Income FY 2019 · Dec 31, 2018 −$110.34K
Operating Income FY 2019 · Dec 31, 2018 −$28.03K
Gross Profit FY 2019 · Dec 31, 2018 $1.16M
Cost Of Revenue FY 2019 · Dec 31, 2018 $1.31M
Revenue FY 2019 · Dec 31, 2018 $2.47M
Stockholders Equity FY 2019 · Dec 31, 2017 $1.42M